Urinary trypsin inhibitor, a Kunitz-type protease inhibitor, modulates tumor necrosis factor-stimulated activation and translocation of protein kinase C in U937 cells

International Journal of Oncology

Volumn 12, Issue 1, 1998, Pages 95-105

  Kobayashi, Hiroshi ^a   Sugino, Dan ^b   Terao, Toshihiko ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Shiga 525 0055   (Japan)

Author keywords

Phorbol ester; Protein kinase C; Tumor necrosis factor ; Urinary trypsin inhibitor; Urokinase type plasminogen activator

Indexed keywords

PHORBOL ESTER; PLASMINOGEN ACTIVATOR; PROTEIN KINASE C; SERINE PROTEINASE INHIBITOR; TRYPSIN INHIBITOR; TUMOR NECROSIS FACTOR; UROKINASE; AMYLASE; GLYCOPROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; TRYPSIN; TUMOR NECROSIS FACTOR ALPHA; ULINASTATIN; VEGETABLE PROTEIN;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CARBOXY TERMINAL SEQUENCE; CELL INVASION; ENZYME INHIBITION; ENZYME STRUCTURE; GENE EXPRESSION REGULATION; METASTASIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CELL STRAIN U937; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; HUMAN; METABOLISM; PROTEIN TRANSPORT; WESTERN BLOTTING;

ALPHA-AMYLASE; BLOTTING, WESTERN; ENZYME ACTIVATION; GLYCOPROTEINS; HUMANS; PLANT PROTEINS; PROTEIN KINASE C; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TRYPSIN; TRYPSIN INHIBITORS; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031964086     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.1.95     Document Type: Article

References (33)

1. Hochstrasser K, Schonberger OL, Rossmanith I and Wachter E: Kunitz-type proteinase inhibitors derived by limited proteolysis of inter-alpha-trypsin inhibitor, V. Hoppe-Seyler's Z Physiol Chem 362: 1357-1362, 1981.
2. Wachter E and Hochstrasser K: Kunitz-type proteinase inhibitors derived by limited proteolysis of inter-alpha-trypsin inhibitor, IV. Hoppe-Seyler Z Physiol Chem 362: 1351-1355, 1981.
3. Hochstrasser K, Albrecht GJ, Schonberger OL and Wachter E: Kunitz-type protcase inhibitors derived by limited proteolysis of inter-alpha-trypsin inhibitor, VIII. Hoppe-Seyler Z Physiol Chem 370: 1689-1696, 1989.
4. Vetr H and Gebhard W: Structure of the human alphal-microglobulin-bikunin gene. Biol Chem Hoppe Seyler 371: 1185-1196, 1990.
5. Kobayashi H, Shinohara H, Takeuchi K, Itoh M, Fujie M, Saitoh M and Terao T: Inhibition of the soluble and the tumor cell receptor-bound plasmin by urinary trypsin inhibitor and subsequent effects on tumor cell invasion and metastasis. Cancer Res 54: 844-849, 1994.
6. Kobayashi H, Gotoh J, Fujie M and Terao T: Characterization of the cellular binding site for the urinary trypsin inhibitor. J Biol Chem 269: 20642-20647, 1994.
7. Kobayashi H, Shinohara H, Ohi H, Sugimura M, Terao T and Fujie M: Urinary trypsin inhibitor (UTI) and fragments derived from UTI by limited proteolysis efficiently inhibit tumor cell invasion. Clin Exp Metastasis 12: 117-128, 1994.
8. Kobayashi H, Fujie M, Shinohara H, Ohi H, Sugimura M and Terao T: Effects of urinary trypsin inhibitor on the invasion of reconstituted basement membranes by ovarian cancer cells. Int J Cancer 57: 378-384, 1994.
9. Kobayashi H, Gotoh J, Hirashima Y, Fujie M and Terao T: Inhibitory effect of a conjugate between human urokinase and urinary trypsin inhibitor on tumor cell invasion in vitro. J Biol Chem 270: 8361-8366, 1995.
10. 2+ in human neutrophils and HUVEC cells. Biochem Biophys Res Commun 207: 324-330, 1995.
11. Maehara K, Kanayama N, Halim A, El-Maradny E, Oda T, Fuhita M and Terao T: Down-regulation of interleukin-8 gene expression in HL60 cell line by human Kunitz-type trypsin inhibitor. Biochem Biophys Res Commun 206: 927-934, 1995.
12. Bazzi MD and Nelsestuen GL: Properties of the protein kinase C-phorbol ester interaction. Biochemistry 28: 3577-3585, 1989.
13. Polio DA, Baldassare JJ, Honda T, Henderson PA, Talkad VD and Gardner JD: Effects of cholecystokinin (CCK) and other secretagogues on isoforms of protein kinase C (PKC) in pancreatic acini. Biochim Biophys Acta 1224: 127-138, 1994.
14. Slater SJ, Kelly MB, Taddeo FJ, Rubin E and Stubbs CD: Evidence for discrete diacylglycerol and phorbol ester activator sites on protein kinase C. J Biol Chem 269: 17160-17165, 1994.
15. Schutze S, Nottrott S, Pfizenmaier K and Kronke M: Tumor necrosis factor signal transduction. Cell-type-specific activation and translocation of protein kinase C. J Immunol 144: 2604-2608, 1990.
16. Schutze S, Berkovic D, Tomsing O, Unger C and Kronke M: Tumor necrosis factor induces rapid production of 1′2′diacyl-glycerol by a phosphatidylcholine-specific phospholipase C. J ExpMed 174: 975-988, 1991.
17. Levin AE: Involvement of protein kinase C and an elastase-like enzyme in the processing of transforming growth factor-alpha in human colon carcinoma cell lines. Int J Cancer 58: 129-134, 1994.
18. Kiu B, Renaud C, Nelson KK, Chen YQ, Bazaz R, Kowynia J, Timar J, Diglio CA and Honn KV: Protein-kinase-C inhibitor calphostin C reduce B16 amelanotic melanoma cell adhesion to endothelium and lung colonization. Int J Cancer 52: 147-152, 1992.
19. Dumont JA, Jones WD and Bitonti AJ: Inhibition of experimental metastasis and cell adhesion of B16F1 melanoma cells by inhibitors of protein kinase C. Cancer Res 52: 1195-1200, 1992.
20. Kobayashi H, Goto J and Terao T: Urinary trypsin inhibitor efficiently inhibits urokinase production in tumor necrosis factor-stimulated cells. Eur J Cell Biol 71: 380-386, 1996.
21. Haimovitz-Friedman A, Balaban N, McLoughlin M, Ehleiter D, Michaeli J, Vlodavsky I and Fuks Z: Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res 54: 2591-2597, 1994.
22. Ways DK, Messer BR, Garris TO, Qin W, Cook PP and Parker PJ: Modulation of protein kinase C-ε by phorbol esters in the monoblastoid U937 cell. Cancer Res 52: 5604-5609, 1992.
23. Puceat M, Hilal-Dandan R, Strulovici B, Brunton LL and Brown JH: Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes. J Biol Chem 269: 16938-16944, 1994.
24. Schutze S, Machleidt T and Kronke M: The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction. J Leukocyte Biol 56: 533-541, 1994.
25. Higuchi M and Aggarwal BB: Microtiter plate radioreceptor assay for tumor necrosis factor and its receptors in large numbers of samples. Anal Biochem 204: 53-58, 1992.
26. Higuchi M and Aggarwal BB: Inhibition of ligand binding and antiproliferative effects of tumor necrosis factor and lymphotoxin by soluble forms of recombinant p60 and p80 receptors. Biochim Biophys Res Commun 182: 638-643, 1992.
27. Totpal K, Chaturvedi MM, LaPushin R and Aggarwal BB: Retinoids downregulate both p60 and p80 forms of tumor necrosis factor receptors in human histiocytic lymphoma U-937 cells. Blood 85: 3547-3555, 1995.
28. Salier JP, Martin JP, Lambin P, McPhee H and Hochstrasser K: Purification of the human serum inter-alpha-trypsin inhibitor by zinc chelate and hydrophobic interaction chromatographies. Anal Biochem 109: 272-283, 1980.
29. Kobayashi H, Gotoh J, Kanayama N, Hirashima Y, Terao T and Sigino D: Inhibition of tumor cell invasion through Matrigel by a peptide derived from domain II region in urinary trypsin inhibitor. Cancer Res 55: 1847-1852, 1995.
30. Hutadilok N, Ghosh P and Brooks PM: Binding of haptoglobin, ITI, and alphal proteinase inhibitor to synovial fluid hyaluronate and the influence of these patients on its degradation by oxygen derived free radicals. Ann Rheum Dis 47: 377-385, 1988.
31. McKeehan WL, Sakagami Y, Hoshi H and McKeehan KA: Two apparent human endothelial cell growth factors from human hepatoma cells are tumor-associated proteinase inhibitors. J Biol Chem 261: 5378-5383, 1986.
32. Niedbala MJ and Stein-Picarella M: Role of protein kinase C in tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator. Blood 81: 2608-2617, 1993.
33. Sitrin RG, Todd III RF, Mizukami IF, Gross TJ, Shollenberger SB and Gyetko MR: Cytokine-specific regulation of urokinase receptor (CD87) expression by U937 mononuclear phagocytes. Blood 84: 1268-1275, 1994.